{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:07:07Z","timestamp":1790863627036,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2166,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/ki.2009.382","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T13:05:10Z","timestamp":1256130310000},"page":"44-50","source":"Crossref","is-referenced-by-count":68,"title":["Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients"],"prefix":"10.1016","volume":"77","author":[{"given":"Sadollah","family":"Abedini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meinitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingar","family":"Holme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Weihrauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fellstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallvard","family":"Holdaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.382_bb0010","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1600-6143.2009.02566.x","article-title":"Kidney and pancreas transplantation in the United States, 1998\u20132007: access for patients with diabetes and end-stage renal disease","volume":"9","author":"McCullough","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2009.382_bb0015","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/ki.2009.382_bb0020","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2009.382_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00129784-200505040-00005","article-title":"Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1038\/ki.2009.382_bb0030","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.TP.0000147338.34323.12","article-title":"Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial","volume":"79","author":"Fellstrom","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2009.382_bb0040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2215\/CJN.06671208","article-title":"Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease","volume":"4","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0045","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1038\/ki.2009.382_bb0055","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.382_bb0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1038\/ki.2009.382_bb0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1038\/ki.2009.382_bb0070","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0075","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/ki.2009.382_bb0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/174182670100800202","article-title":"Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data","volume":"8","author":"Holdaas","year":"2001","journal-title":"J Cardiovasc Risk"},{"key":"10.1038\/ki.2009.382_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2009.382_bb0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1440-1797.2007.00840.x","article-title":"Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease","volume":"12","author":"Ueda","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2009.382_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.HYP.29.1.242","article-title":"Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension","volume":"29","author":"Matsuoka","year":"1997","journal-title":"Hypertension"},{"key":"10.1038\/ki.2009.382_bb0105","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"Boger","year":"1998","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.382_bb0110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","article-title":"Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase","volume":"106","author":"Lin","year":"2002","journal-title":"Circulation"},{"key":"10.1038\/ki.2009.382_bb0115","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.2001.59780014.x","article-title":"Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients","volume":"78","author":"Fleck","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2009.382_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.abb.2003.07.006","article-title":"Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress","volume":"420","author":"Valgimigli","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/ki.2009.382_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0130","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/HJH.0b013e328311d223","article-title":"Arterial stiffness and renal transplantation","volume":"26","author":"Safar","year":"2008","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2009.382_bb0135","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/ndt\/gfm379","article-title":"Arterial stiffness and wave reflections in renal transplant recipients","volume":"22","author":"Verbeke","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.382_bb0140","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/HJH.0b013e32830ef940","article-title":"Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients","volume":"26","author":"Seckinger","year":"2008","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2009.382_bb0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/08860220701460046","article-title":"The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients","volume":"29","author":"Strozecki","year":"2007","journal-title":"Ren Fail"},{"key":"10.1038\/ki.2009.382_bb0150","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"Stuhlinger","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/ki.2009.382_bb0155","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/01.tp.0000183750.22675.be","article-title":"Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation","volume":"80","author":"Yilmaz","year":"2005","journal-title":"Transplantation"},{"key":"10.1038\/ki.2009.382_bb0160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e318166a3a4","article-title":"Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus","volume":"85","author":"Potena","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2009.382_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TP.0b013e31818bfce8","article-title":"Cerebrovascular events in renal transplant recipients","volume":"87","author":"Abedini","year":"2009","journal-title":"Transplantation"},{"key":"10.1038\/ki.2009.382_bb0170","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.STR.0000231640.32543.11","article-title":"ADMA increases arterial stiffness and decreases cerebral blood flow in humans","volume":"37","author":"Kielstein","year":"2006","journal-title":"Stroke"},{"key":"10.1038\/ki.2009.382_bb0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.107.156596","article-title":"Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg","volume":"28","author":"Leong","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/ki.2009.382_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpneph0143","article-title":"Arginine, arginine analogs and nitric oxide production in chronic kidney disease","volume":"2","author":"Baylis","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2009.382_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(03)00030-8","article-title":"ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease","volume":"4","author":"Boger","year":"2003","journal-title":"Atheroscler Suppl"},{"key":"10.1038\/ki.2009.382_bb0190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00726-005-0268-8","article-title":"Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?","volume":"30","author":"Busch","year":"2006","journal-title":"Amino Acids"},{"key":"10.1038\/ki.2009.382_bb0195","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1172\/JCI115849","article-title":"Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage","volume":"90","author":"Baylis","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.382_bb0200","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0272-6386(99)70229-5","article-title":"Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model","volume":"33","author":"Benigni","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.382_bb0205","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1097\/01.ASN.0000086476.48686.7D","article-title":"Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase","volume":"14","author":"Erdely","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0210","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1681\/ASN.V571498","article-title":"Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy","volume":"5","author":"Fujihara","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0002-9440(10)64175-2","article-title":"Nitric oxide modulates vascular disease in the remnant kidney model","volume":"161","author":"Kang","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2009.382_bb0220","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1681\/ASN.2004090735","article-title":"Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase","volume":"16","author":"Scalera","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.382_bb0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.2001.5575","article-title":"Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography","volume":"303","author":"Teerlink","year":"2002","journal-title":"Anal Biochem"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815541215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815541215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:39:23Z","timestamp":1626867563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815541215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0085253815541215"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.382","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}